tiprankstipranks
Advertisement

AVDE - ETF AI Analysis

Compare

Top Page

AVDE

Avantis International Equity ETF (AVDE)

Rating:65Neutral
Price Target:
AVDE, the Avantis International Equity ETF, has a solid overall rating, largely supported by strong global leaders like ASML and Novartis, which bring robust profitability, positive growth outlooks, and supportive technical trends to the portfolio. Financially sound holdings such as HSBC, Shell, and Roche further strengthen the fund, though names like Allianz, Safran, and BHP introduce some drag due to bearish or neutral momentum, profitability challenges, and sector-specific headwinds. The main risk factor is the fund’s exposure to company- and sector-specific issues abroad, such as regional banking challenges and commodity-related pressures, which can add volatility to returns.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid momentum in its international stock holdings.
Healthy Top Holdings Performance
Many of the largest positions, including companies in technology, energy, and financials, have shown strong performance, helping support the fund’s overall returns.
Broad Global Diversification
The fund spreads its investments across many countries such as Japan, the UK, France, Canada, and others, which helps reduce the impact of problems in any single market.
Negative Factors
Recent Short-Term Weakness
The ETF has shown slightly negative performance over the past month, which may signal short-term volatility or a pause in its upward trend.
Meaningful Exposure to a Single Country
A relatively large portion of the portfolio is invested in one country, which can increase risk if that market faces economic or political challenges.
Moderate Expense Ratio
While not extremely high, the fund’s ongoing fees are noticeable and will slightly reduce investors’ net returns over time compared with very low-cost alternatives.

AVDE vs. SPDR S&P 500 ETF (SPY)

AVDE Summary

AVDE, the Avantis International Equity ETF, invests in a wide mix of companies outside the U.S., aiming to capture the overall international stock market rather than track a specific index. It holds well-known global names like ASML Holding, HSBC, Shell, and Novartis, spread across many countries and sectors such as financials, industrials, and technology. Someone might invest in AVDE to diversify beyond U.S. stocks and seek long-term growth from international markets. A key risk is that its value can rise or fall with global stock markets and currency movements, so returns may be volatile.
How much will it cost me?The Avantis International Equity ETF (AVDE) has an expense ratio of 0.23%, meaning you’ll pay $2.30 per year for every $1,000 invested. This cost is lower than average for actively managed funds because AVDE uses a blend of quantitative techniques and fundamental insights to manage its portfolio efficiently.
What would affect this ETF?The Avantis International Equity ETF (AVDE) could benefit from growth in developed markets outside the U.S., particularly if sectors like financials and industrials, which make up a significant portion of its holdings, experience strong performance due to favorable economic conditions or technological advancements. However, it may face challenges from global economic slowdowns, regulatory changes, or geopolitical tensions that impact key regions or companies like Shell, Roche, and Toyota Motor. Interest rate fluctuations and currency risks could also influence the ETF's returns, given its international exposure.

AVDE Top 10 Holdings

AVDE leans on a mix of global heavyweights, with Dutch chip-equipment maker ASML acting as a key engine of growth thanks to its strong, rising performance. Financials are another big pillar: HSBC, BBVA, UBS, and Allianz have generally been climbing, giving the fund a solid banking backbone. On the softer side, Roche has been lagging and Shell looks a bit tired lately, which can dampen returns. Overall, the ETF is broadly diversified across non-U.S. developed markets, with no single stock dominating the story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding1.46%$261.35M$691.34B148.66%
81
Outperform
Roche Holding AG0.91%$163.25M$324.59B28.18%
73
Outperform
HSBC Holdings0.88%$158.00M$352.71B56.59%
78
Outperform
Shell0.86%$154.28M$242.98B21.51%
78
Outperform
Novartis0.58%$104.53M$280.21B32.93%
80
Outperform
Banco Bilbao0.58%$103.61M$145.40B66.18%
76
Outperform
UBS Group AG0.56%$100.34M$159.03B34.91%
BHP Group0.56%$99.94M$211.75B54.68%
73
Outperform
Allianz0.55%$98.09M€161.36B22.20%
67
Neutral
SAFRAN SA0.54%$96.82M€136.46B15.16%
67
Neutral

AVDE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
89.55
Positive
100DMA
87.89
Positive
200DMA
84.80
Positive
Market Momentum
MACD
0.10
Positive
RSI
51.17
Neutral
STOCH
57.12
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVDE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 89.61, equal to the 50-day MA of 89.55, and equal to the 200-day MA of 84.80, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 51.17 is Neutral, neither overbought nor oversold. The STOCH value of 57.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVDE.

AVDE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$17.68B0.23%
65
Neutral
$20.73B0.27%
65
Neutral
$19.09B0.36%
59
Neutral
$17.16B0.18%
65
Neutral
$14.52B0.22%
64
Neutral
$2.32B0.54%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVDE
Avantis International Equity ETF
89.81
17.33
23.91%
DFIV
Dimensional International Value ETF
AVDV
Avantis International Small Cap Value ETF
DFAI
Dimensional International Core Equity Market ETF
DFIC
Dimensional International Core Equity 2 ETF
CGIE
Capital Group International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement